Clinical Trials Browser

Phase 2 × etirinotecan pegol × Other solid neoplasm × Clear all

NCT01457118 2021-07-12

An Extension Study of NKTR-102 in Cancer Patients Previously Enrolled in NKTR-102 Studies

Phase 2 Completed

27 enrolled 18 charts

Other solid neoplasm

Malignant Solid Tumor